AI Science Tracker
EN

Combination of machine learning-based bulk and single-cell genomics reveals necroptosis-related molecular subtypes and immunological features in autism spectrum disorder

Department of Pharmacy, Fujian Children's Hospital, Fuzhou, China; Department of Pediatric Endocrinology, Fujian Children's Hospital, Fuzhou, China; Department of Rehabilitation Medicine, Fujian Children's Hospital, Fuzhou, China; Department of Pediatric Intensive Care Unit, Fujian Children's Hospital, Fuzhou, China; Department of Geriatric Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China · 24 Apr 2023 · medicine

Discovery

Combination of machine learning-based bulk and single-cell genomics reveals necroptosis-related molecular subtypes and immunological features in autism spectrum disorder

Source check: Source checked. Not independent scientific confirmation.

Finding: The article reports necroptosis-associated molecular subgroups and a candidate four-gene signature in ASD; the retrospective result does not establish causal subtypes or clinical benefit. Two GEO datasets and peripheral-blood RT-PCR are reported as validation; the paper notes limited performance/sample evidence and need for larger cohorts.

Technology: LASSO, random-forest feature selection and SVM-RFE are used to identify candidate genes and build subgroup/signature analyses.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
LASSO, random-forest feature selection and SVM-RFE are used to identify candidate genes and build subgroup/signature analyses.
Test and result
The article reports necroptosis-associated molecular subgroups and a candidate four-gene signature in ASD; the retrospective result does not establish causal subtypes or clinical benefit.
Limitation / still unknown
Two GEO datasets and peripheral-blood RT-PCR are reported as validation; the paper notes limited performance/sample evidence and need for larger cohorts.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1139420/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.